Showing results (111-120 of 117) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
The Lancet. Haematology|January 16, 2019
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a studyAnas Younes, Joshua Brody, Cecilia Carpio, et al.Cell|November 23, 2023
S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axisLiwen Deng, Flavia Costa, Kimbria J Blake, et al.Blood Advances|October 1, 2020
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)Katharina Thom, Anthonie W A Lensing, Ildar Nurmeev, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE TrialMarco Ladetto, Katja Gutmair, Rita Tavarozzi, et al.Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.European Journal of Preventive Cardiology|July 22, 2025
Refining current risk stratification guidelines for pregnant women with Fontan circulation: lessons from PROFAT registryMagalie Ladouceur, Andrea Girnius, Dominica Zentner, et al.The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.Pageof 12